Creative Medical Technology Holdings, Inc. (CELZ) Current Ratio
- Current ratio · latest quarter: Value 12.91×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 12.91× | Current assets / current liabilities. $9.02M ÷ $698.60K ≈ 12.91× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 9.02M USD | Assets, Current |
| Current obligations | 698.60K USD | Liabilities, Current |
| Cash and equivalents | (m) | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | (m) | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | 125.00K USD | Inventory, Net |
| Payables | 684.40K USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $9.02M | $698.60K | (m) | (m) | (m) | $125.00K | $684.40K | (m) | 12.91× |
| 2026-03-31 | $6.06M | $307.65K | (m) | (m) | (m) | $125.00K | $293.45K | (m) | 19.69× |
| 2025-12-31 | $7.40M | $284.88K | (m) | (m) | (m) | $0.00 | $270.69K | (m) | 25.97× |
| 2025-09-30 | $5.41M | $261.35K | (m) | (m) | (m) | $994.00 | $247.16K | (m) | 20.71× |
| 2025-06-30 | $6.63M | $277.64K | (m) | (m) | (m) | $994.00 | $263.45K | (m) | 23.89× |
| 2025-03-31 | $7.84M | $286.39K | (m) | (m) | (m) | $994.00 | $272.19K | (m) | 27.39× |
| 2024-12-31 | $6.14M | $327.64K | (m) | (m) | (m) | $2.19K | $273.53K | (m) | 18.73× |
| 2024-09-30 | $6.33M | $330.91K | (m) | (m) | (m) | $3.39K | $273.79K | (m) | 19.13× |
| 2024-06-30 | $7.60M | $376.27K | (m) | (m) | (m) | $3.39K | $322.16K | (m) | 20.21× |
| 2024-03-31 | $9.20M | $390.96K | (m) | (m) | (m) | $6.59K | $336.85K | (m) | 23.54× |
| 2023-12-31 | $10.27M | $371.39K | (m) | (m) | (m) | $6.59K | $317.28K | (m) | 27.65× |
| 2023-09-30 | $12.04M | $421.16K | $4.51M | (m) | (m) | $7.79K | $367.05K | (m) | 28.60× |
| 2023-06-30 | $13.73M | $398.53K | $3.99M | (m) | (m) | $10.19K | $344.41K | (m) | 34.46× |
| 2023-03-31 | $14.81M | $407.54K | (m) | (m) | (m) | $10.19K | $353.42K | (m) | 36.35× |
| 2022-12-31 | $18.75M | $3.32M | (m) | (m) | (m) | $10.19K | $3.27M | (m) | 5.64× |
| 2022-09-30 | $22.01M | $396.96K | (m) | (m) | $0.00 | $15.89K | $327.84K | (m) | 55.44× |
| 2022-06-30 | $22.95M | $389.80K | $22.86M | (m) | (m) | $20.63K | $310.68K | (m) | 58.88× |
| 2022-03-31 | $9.23M | $379.80K | $9.15M | (m) | (m) | $14.15K | $335.68K | (m) | 24.29× |
| 2021-12-31 | $10.74M | $1.05M | (m) | (m) | $2.48K | $10.87K | $761.86K | (m) | 10.22× |
| 2021-09-30 | $2.58M | $3.50M | $2.38M | (m) | (m) | (m) | $454.52K | (m) | 0.74× |
| 2021-06-30 | $158.59K | $1.45M | $158.59K | (m) | (m) | (m) | $365.04K | (m) | 0.11× |
| 2021-03-31 | $275.13K | $3.31M | $275.13K | (m) | (m) | (m) | $356.00K | (m) | 0.08× |
| 2020-12-31 | $98.01K | $40.52M | $98.01K | (m) | (m) | $0.00 | $350.90K | (m) | 0.00× |
| 2020-09-30 | $38.71K | $3.20M | $38.71K | (m) | $0.00 | $0.00 | $344.45K | (m) | 0.01× |
| 2020-06-30 | $39.62K | $4.65M | $37.02K | (m) | $1.40K | $1.20K | $380.61K | (m) | 0.01× |
| 2020-03-31 | $49.53K | $3.65M | (m) | (m) | $8.40K | $2.80K | $386.56K | (m) | 0.01× |
| 2019-12-31 | $94.25K | $8.60M | $88.65K | (m) | $5.60K | (m) | $320.79K | (m) | 0.01× |
| 2019-09-30 | $182.74K | $3.89M | (m) | (m) | $24.50K | (m) | $323.80K | (m) | 0.05× |
| 2019-06-30 | $205.11K | $3.00M | (m) | (m) | $1.00K | (m) | $320.44K | (m) | 0.07× |
| 2019-03-31 | $419.64K | $4.18M | $419.48K | (m) | $163.00 | (m) | $342.80K | (m) | 0.10× |
| 2018-12-31 | $313.66K | $4.47M | $304.06K | (m) | $9.60K | (m) | $331.84K | (m) | 0.07× |
| 2018-09-30 | $186.83K | $7.71M | $172.83K | (m) | $14.00K | (m) | $242.84K | (m) | 0.02× |
| 2018-06-30 | $105.30K | $10.87M | $100.50K | (m) | $4.80K | (m) | $272.83K | (m) | 0.01× |
| 2018-03-31 | $111.91K | $8.22M | $102.31K | (m) | $9.60K | (m) | $233.43K | (m) | 0.01× |
| 2017-12-31 | $18.50K | $2.44M | $13.70K | (m) | $4.80K | (m) | $237.57K | (m) | 0.01× |
| 2017-09-30 | $21.22K | $1.27M | $21.22K | (m) | (m) | (m) | $157.10K | (m) | 0.02× |
| 2017-06-30 | $104.40K | $1.31M | $104.40K | (m) | (m) | (m) | $53.20K | (m) | 0.08× |
| 2017-03-31 | $98.12K | $468.87K | $98.12K | (m) | (m) | (m) | $96.88K | (m) | 0.21× |
| 2016-12-31 | $221.87K | $453.86K | $221.87K | (m) | $0.00 | (m) | $66.39K | (m) | 0.49× |
| 2016-09-30 | $33.46K | $445.96K | $33.46K | (m) | (m) | (m) | $44.85K | (m) | 0.08× |
| 2015-12-31 | $49.60K | $100.00 | $100.00 | (m) | (m) | (m) | $0.00 | (m) | 496.00× |
| 2015-03-31 | $583.00 | $162.90K | $583.00 | (m) | (m) | (m) | $12.51K | (m) | 0.00× |
| 2014-12-31 | $954.00 | $154.00K | $954.00 | (m) | (m) | (m) | $10.19K | (m) | 0.01× |
| 2014-09-30 | $1.29K | $147.83K | $1.29K | (m) | (m) | (m) | $11.32K | (m) | 0.01× |
| 2014-06-30 | $1.29K | $142.08K | $1.29K | (m) | (m) | (m) | $10.42K | (m) | 0.01× |
| 2014-03-31 | $1.29K | $136.34K | $1.29K | (m) | (m) | (m) | $12.04K | (m) | 0.01× |
| 2013-12-31 | $374.00 | $125.41K | $374.00 | (m) | (m) | (m) | $8.08K | (m) | 0.00× |
| 2013-09-30 | $398.00 | $119.38K | $398.00 | (m) | (m) | (m) | $8.10K | (m) | 0.00× |
| 2013-06-30 | $403.00 | $113.94K | $403.00 | (m) | (m) | (m) | $6.71K | (m) | 0.00× |
| 2013-03-31 | $1.78K | $109.58K | $597.00 | (m) | (m) | (m) | $9.79K | (m) | 0.02× |
| 2012-12-31 | $1.57K | $99.32K | $781.00 | (m) | (m) | (m) | $9.98K | (m) | 0.02× |
| 2012-09-30 | $1.15K | $92.91K | $756.00 | (m) | (m) | (m) | $8.30K | (m) | 0.01× |
| 2012-06-30 | $531.00 | $86.78K | $531.00 | (m) | (m) | (m) | $7.80K | (m) | 0.01× |
| 2012-03-31 | $1.63K | $82.85K | $631.00 | (m) | (m) | (m) | $7.71K | (m) | 0.02× |
| 2011-12-31 | $3.10K | $75.27K | $1.10K | (m) | (m) | (m) | $7.87K | (m) | 0.04× |
| 2011-09-30 | $4.21K | $69.57K | $1.21K | (m) | (m) | (m) | $3.35K | (m) | 0.06× |
| 2011-06-30 | $400.00 | $61.16K | $400.00 | (m) | (m) | (m) | (m) | (m) | 0.01× |
| 2010-12-31 | $414.00 | $48.52K | $414.00 | (m) | (m) | (m) | $0.00 | (m) | 0.01× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |